Preferred Label : Siremadlin Succinate;
NCIt synonyms : HDM201 Succinate; NVP-HDM201-BBA;
NCIt definition : The succinate form of siremadlin, an orally bioavailable human double minute 2 homolog
(HDM2) inhibitor with potential antineoplastic activity. Siremadlin inhibits the binding
of the HDM2 protein to the transcriptional activation domain of the tumor suppressor
protein p53. By preventing this HDM2-p53 interaction, the proteasome-mediated enzymatic
degradation of p53 is inhibited, which may result in the restoration of both p53 signaling
and p53-mediated induction of tumor cell apoptosis. HDM2, a zinc finger protein and
negative regulator of the p53 pathway, is often overexpressed in cancer cells and
has been implicated in cancer cell proliferation and survival.;
UNII : 0XPX99P4ZT;
CAS number : 1638193-48-2; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1638193-48-2
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
NCI Metathesaurus CUI : CL1798506;
Origin ID : C189975;
UMLS CUI : C5708855;
Semantic type(s)
- concept_is_in_subset
- has_target
